uniQure Announces Dosing of First Patients in Europe Open-Label Trial of AMT-130katie8288Feb 7, 20220 min read
Skyhawk Therapeutics Announces the Expansion of its Global Pivotal trial into the United States, Canada, and the United Kingdom
Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease
Comments